Dr Michael A Wiener, DMD | |
412 St Rt 37, Saint Regis Mohawk Health Services Dental, Akwesasne, NY 13655-2277 | |
(518) 358-3141 | |
(518) 358-2797 |
Full Name | Dr Michael A Wiener |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 412 St Rt 37, Akwesasne, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528040078 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 051643 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael A Wiener, DMD 412 St Rt 37, Saint Regis Mohawk Health Services Dental, Akwesasne, NY 13655-2277 Ph: (518) 358-3141 | Dr Michael A Wiener, DMD 412 St Rt 37, Saint Regis Mohawk Health Services Dental, Akwesasne, NY 13655-2277 Ph: (518) 358-3141 |
News Archive
A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans - even those resistant to conventional therapies - according to results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
The Translational Genomics Research Institute (TGen) provides Arizona with an annual total economic impact of $77.4 million, according to the results of an independent analysis released today.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.
Today, the U.S. Food and Drug Administration issued guidance on the use of dry heat to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply of respirators during the COVID-19 public health emergency.
The key symptom of COPD is breathlessness, especially during daily activity, and the breathlessness is in addition to cough and chest tightness. The difficulty in managing this disease is that it's a disease that progresses with age.
› Verified 5 days ago